1
|
Lenci E, Trabocchi A. Diversity‐Oriented Synthesis and Chemoinformatics: A Fruitful Synergy towards Better Chemical Libraries. European J Org Chem 2022. [DOI: 10.1002/ejoc.202200575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Elena Lenci
- Universita degli Studi di Firenze Department of Chemistry Via della Lastruccia 1350019Italia 50019 Sesto Fiorentino ITALY
| | - Andrea Trabocchi
- University of Florence: Universita degli Studi di Firenze Department of Chemistry "Ugo Schiff" ITALY
| |
Collapse
|
2
|
Saldívar-González FI, Valli M, Andricopulo AD, da Silva Bolzani V, Medina-Franco JL. Chemical Space and Diversity of the NuBBE Database: A Chemoinformatic Characterization. J Chem Inf Model 2018; 59:74-85. [DOI: 10.1021/acs.jcim.8b00619] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- Fernanda I. Saldívar-González
- School of Chemistry, Department of Pharmacy, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City 04510, Mexico
| | - Marilia Valli
- Nuclei of Bioassays, Biosynthesis and Ecophysiology of Natural Products (NuBBE), Department of Organic Chemistry, Institute of Chemistry, Sao Paulo State University - UNESP, 14800-060 Araraquara, Sao Paulo, Brazil
| | - Adriano D. Andricopulo
- Laboratório de Química Medicinal e Computacional (LQMC), Centro de Pesquisa e Inovação em Biodiversidade e Fármacos, Institute of Physics of Sao Carlos, University of Sao Paulo - USP, 13563-120 Sao Carlos, Sao Paulo, Brazil
| | - Vanderlan da Silva Bolzani
- Nuclei of Bioassays, Biosynthesis and Ecophysiology of Natural Products (NuBBE), Department of Organic Chemistry, Institute of Chemistry, Sao Paulo State University - UNESP, 14800-060 Araraquara, Sao Paulo, Brazil
| | - José L. Medina-Franco
- School of Chemistry, Department of Pharmacy, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City 04510, Mexico
| |
Collapse
|
3
|
Alonso F, Quezada MJ, Gola GF, Richmond V, Cabrera GM, Barquero AA, Ramírez JA. A Minimalist Approach to the Design of Complexity-Enriched Bioactive Small Molecules: Discovery of Phenanthrenoid Mimics as Antiproliferative Agents. ChemMedChem 2018; 13:1732-1740. [DOI: 10.1002/cmdc.201800295] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2018] [Indexed: 12/18/2022]
Affiliation(s)
- Fernando Alonso
- Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires, Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
- CONICET - Universidad de Buenos Aires; Unidad de Microanálisis y Métodos Físicos Aplicados a Química Orgánica (UMYMFOR), Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
| | - María Josefina Quezada
- CONICET - Universidad de Buenos Aires; Instituto de Quimica Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
- Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires, Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
| | - Gabriel F. Gola
- Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires, Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
- CONICET - Universidad de Buenos Aires; Unidad de Microanálisis y Métodos Físicos Aplicados a Química Orgánica (UMYMFOR), Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
| | - Victoria Richmond
- Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires, Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
- CONICET - Universidad de Buenos Aires; Unidad de Microanálisis y Métodos Físicos Aplicados a Química Orgánica (UMYMFOR), Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
| | - Gabriela M. Cabrera
- Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires, Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
- CONICET - Universidad de Buenos Aires; Unidad de Microanálisis y Métodos Físicos Aplicados a Química Orgánica (UMYMFOR), Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
| | - Andrea A. Barquero
- CONICET - Universidad de Buenos Aires; Instituto de Quimica Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
- Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires, Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
| | - Javier A. Ramírez
- Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires, Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
- CONICET - Universidad de Buenos Aires; Unidad de Microanálisis y Métodos Físicos Aplicados a Química Orgánica (UMYMFOR), Ciudad Universitaria; Ciudad Autónoma de Buenos Aires C1428EGA Argentina
| |
Collapse
|
4
|
|
5
|
Keserű GM, Erlanson DA, Ferenczy GG, Hann MM, Murray CW, Pickett SD. Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia. J Med Chem 2016; 59:8189-206. [DOI: 10.1021/acs.jmedchem.6b00197] [Citation(s) in RCA: 154] [Impact Index Per Article: 19.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- György M. Keserű
- Research
Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudósok
körútja 2, H-1117, Budapest, Hungary
| | - Daniel A. Erlanson
- Carmot Therapeutics, Inc. 409 Illinois Street, San Francisco, California 94158, United States
| | - György G. Ferenczy
- Research
Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudósok
körútja 2, H-1117, Budapest, Hungary
| | - Michael M. Hann
- Medicines
Research Centre, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K
| | - Christopher W. Murray
- Astex Pharmaceuticals, 436 Cambridge Science Park, Milton
Road, Cambridge CB4 0QA, U.K
| | - Stephen D. Pickett
- Medicines
Research Centre, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K
| |
Collapse
|
6
|
Mignani S, Huber S, Tomás H, Rodrigues J, Majoral JP. Compound high-quality criteria: a new vision to guide the development of drugs, current situation. Drug Discov Today 2016; 21:573-84. [PMID: 26802700 DOI: 10.1016/j.drudis.2016.01.005] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2015] [Revised: 01/12/2016] [Accepted: 01/13/2016] [Indexed: 02/08/2023]
Abstract
For several decades, the pharmaceutical industry has suffered due to major issues such as reductions of the number of FDA approved drugs and biologics. Several analyses have been highlighted that the 'druglikeness' is one of the strategies to improve succeed rates of screening such as, for instance, high-throughput screening (HTS), and then hits (as starting point), leads and clinical candidates. It is clear that the improvement of compound quality accelerates the drug discovery projects. The monitoring of several indices to avoid 'molecular obesity' (ADMET problems) of final drugs from good-quality 'low-fat' starting points represents today a powerful strategy of optimization process. The development of the new guides to find drugs highlighting attempts at improving the attrition rate from hits to final medicines by focusing on how to improve the druggability of hits, leads and drugs during the drug discovery process represents a key approach to design next better generation of medicines.
Collapse
Affiliation(s)
- Serge Mignani
- Université Paris Descartes, PRES Sorbonne Paris Cité, CNRS UMR 860, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologique, 45, rue des Saints Pères, 75006 Paris, France.
| | - Scot Huber
- SCYNEXIS, Inc., P.O. Box 12878, Research Triangle Park, NC 27709, USA
| | - Helena Tomás
- CQM - Centro de Química da Madeira, MMRG, Universidade da Madeira, Campus Universitário da Penteada, 9000-390 Funchal, Portugal
| | - João Rodrigues
- CQM - Centro de Química da Madeira, MMRG, Universidade da Madeira, Campus Universitário da Penteada, 9000-390 Funchal, Portugal.
| | - Jean-Pierre Majoral
- Laboratoire de Chimie de Coordination du CNRS, 205 route de Narbonne, BP 44099, 31077 Toulouse Cedex 4, France; Université de Toulouse, UPS, INPT, 31077 Toulouse Cedex 4, France.
| |
Collapse
|
7
|
Affiliation(s)
- Thomas Böttcher
- Department of Chemistry and
Konstanz Research School Chemical Biology, University of Konstanz, Universitätsstrasse 10, 78457 Konstanz, Germany
| |
Collapse
|
8
|
Li J, Eastgate MD. Current complexity: a tool for assessing the complexity of organic molecules. Org Biomol Chem 2015; 13:7164-76. [PMID: 25962620 DOI: 10.1039/c5ob00709g] [Citation(s) in RCA: 60] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Molecular complexity for a synthetic organic chemist is difficult to define, though intuitively known. Despite the importance of this concept, the quantitative assessment of complexity within organic chemistry has remained a challenge. We report here on the development of an approach for generating a unique complexity index, which is reflective of both intrinsic molecular complexity and extrinsic synthetic complexity. This index is based on a community's perception of complexity, within the context of current technology, calculating a molecule's current complexity. Our approach allows for a direct comparison between molecules, the analysis of trends within research programs, it enables an assessment (and comparison) of new synthetic approaches to known molecules and is capable of following a molecule's apparent complexity as it changes over time.
Collapse
Affiliation(s)
- Jun Li
- Chemical Development, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08903, USA.
| | | |
Collapse
|